COMMUNIQUÉS West-GlobeNewswire

Executive Wellness Retreats: Grey Matters International Announces Expansion of Neuroscience-Based Programs
09/10/2025
Tulsa, Oklahoma , Oct. 09, 2025 (GLOBE NEWSWIRE) -- Grey Matters International, Inc. , a neuroscience-driven mental health organization founded by Kevin J. Fleming, Ph.D., today announced the expansion of its executive [...]
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
09/10/2025
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced [...]
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
09/10/2025
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical data at EADV 2025 for GS-6791 (NX-0479), a novel IRAK4 [...]
Procedure of the Annual General Meeting
09/10/2025
ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 9 October 2025 at 5.30 p.m. at Nordsjællands KonferenceCenter. At the Annual General [...]
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/10/2025
REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
09/10/2025
Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlook WARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) ( [...]
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
09/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
09/10/2025
MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
09/10/2025
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, [...]
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
09/10/2025
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today [...]
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
09/10/2025
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition and behavior at 2 years; results contrast with minimal change in natural [...]
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
09/10/2025
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability 1 through 2027, independent of Star ratings [...]
VitalHub Announces Novari Health Deployment in the UK
09/10/2025
TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced that Novari Health (“Novari”), a VitalHub company, has been commissioned for its first UK [...]
Palisade Bio Announces Cancellation of Special Meeting of Stockholders
09/10/2025
Carlsbad, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients [...]
Portsmouth Square, Inc. Announces FY2025 Results; Going-Concern Doubt Alleviated Following March 2025 Hotel Refinancing and Strong Operating Trends
09/10/2025
Los Angeles, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. ("Portsmouth" or the "Company") (OTC: PRSI) reported results for the fiscal year ended June 30, 2025 and announced that the substantial doubt [...]
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
09/10/2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market [...]
CERTIFIED Opens First Columbus Dispensary, Revives Local Landmark with Drive-Thru Cannabis Experience
09/10/2025
Ohio-born cannabis brand brings personal story, community focus, and premium products to Silver Drive location COLUMBUS, Ohio, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CERTIFIED , a family-owned, vertically integrated Ohio [...]
ICPO Foundation welcomes 24 new ICPO Theranostics Clinical Centers of Excellence to its global network of 45 centers
09/10/2025
The Center Certification Ceremony took place during the ICPO Reception on the occasion of the EANM conference on Oct 4, 2025, in Barcelona. October 9, 2025 – Wiesbaden, Germany. The International Centers for Precision [...]
Idorsia launches an offering of registered shares – to fund the company to overall profitability
09/10/2025
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR [...]

Pages